Excitotoxic mechanisms of epileptic brain damage
- PMID: 3706027
Excitotoxic mechanisms of epileptic brain damage
Abstract
It is well established that the putative excitatory neurotransmitters, glutamate (Glu) and aspartate (Asp), are neurotoxins that have the potential of destroying central neurons by an excitatory mechanism. Kainic acid (KA), a rigid structural analog of Glu, powerfully reproduces the excitatory neurotoxic (excitotoxic) action of Glu on central neurons and, in addition, causes sustained limbic seizures and a pattern of seizure-linked brain damage in rats that closely resembles that observed in human epilepsy. In the course of studying the seizure-related brain damage syndrome induced by KA, we observed that a similar type of brain damage occurs as a consequence of sustained seizure activity induced by any of a variety of methods. These included intraamygdaloid or supradural administration of known convulsants such as bicuculline, picrotoxin and folic acid, or systemic administration of lithium and cholinergic agonists or cholinesterase inhibitors that have not commonly been viewed as convulsants. We have further observed that this type of brain damage can be reproduced in the hippocampus by persistent electrical stimulation of the perforant path, a major excitatory input to the hippocampus that is thought to use Glu as transmitter. It is a common feature of all such neurotoxic processes that the acute cytopathology resembles the excitotoxic type of damage induced by Glu or Asp, which is acute swelling of dendrites and vacuolar degeneration of neuronal soma, without acute changes in axons or axon terminals. We have found that the seizure-brain damage syndrome induced by cholinergic agents can be prevented by pretreatment with atropine and that the syndrome induced by any of the above methods, cholinergic or noncholinergic, can be either prevented or aborted respectively by either pre-or posttreatment with diazepam. Our findings in experimental animals may be summarized in terms of their potential relevance to human epilepsy as follows. Sustained complex partial seizure activity consistently results in cellular damage if allowed to continue for longer than 1 hr. Hippocampal, or Ammon's horn, sclerosis is the primary pathological result. It may be a priority goal, therefore, in the management of human epilepsy to control such seizure activity within very narrow limits. This proposal is discussed in terms of three major transmitter systems that may be involved; cholinergic, GABAergic, and glutamergic/aspartergic. The cholinergic system may play a role in generating or maintaining this type of seizure activity, and anticholinergics may protect against it provided they are given prior to commencement of behavioral seizures.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Only certain anticonvulsants protect against kainate neurotoxicity.Neurobehav Toxicol Teratol. 1981 Fall;3(3):355-61. Neurobehav Toxicol Teratol. 1981. PMID: 6793881
-
Damage induced by systemic kainic acid in rats is dependent upon seizure activity--a behavioral and morphological study.Neurotoxicology. 1986 Fall;7(3):187-202. Neurotoxicology. 1986. PMID: 3822260
-
Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids.J Pharmacol Exp Ther. 1983 May;225(2):399-406. J Pharmacol Exp Ther. 1983. PMID: 6842403
-
Seizure-induced hippocampal damage in the mature and immature brain.Epileptic Disord. 2002 Jun;4(2):83-97. Epileptic Disord. 2002. PMID: 12105072 Review.
-
Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis.Adv Neurol. 1986;44:411-33. Adv Neurol. 1986. PMID: 2871722 Review.
Cited by
-
Therapeutic efficacy of chlorogenic acid on cadmium-induced oxidative neuropathy in a murine model.Exp Ther Med. 2015 May;9(5):1887-1894. doi: 10.3892/etm.2015.2367. Epub 2015 Mar 17. Exp Ther Med. 2015. PMID: 26136910 Free PMC article.
-
Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene.Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12096-101. doi: 10.1073/pnas.96.21.12096. Proc Natl Acad Sci U S A. 1999. PMID: 10518582 Free PMC article.
-
In vivo glutamate clearance defects in a mouse model of Lafora disease.Exp Neurol. 2019 Oct;320:112959. doi: 10.1016/j.expneurol.2019.112959. Epub 2019 May 18. Exp Neurol. 2019. PMID: 31108086 Free PMC article.
-
Afferents to the seizure-sensitive neurons in layer III of the medial entorhinal area: a tracing study in the rat.Exp Brain Res. 1996 May;109(2):209-18. doi: 10.1007/BF00231782. Exp Brain Res. 1996. PMID: 8738371
-
Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists.Metab Brain Dis. 1996 Jun;11(2):125-41. doi: 10.1007/BF02069500. Metab Brain Dis. 1996. PMID: 8776715